ArticleCancer immunology, immunotherapy : CII2024

A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy.

Zehao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.